The epidemiology of invasive Streptococcus pneumoniae disease in Croatian children.
BACKGROUND
Invasive pneumococcal disease (IPD) is a major medical problem in childhood. Pneumococcal conjugate vaccines (PCVs) offer a new possibility to reduce the incidence of pneumococcal infections, especially IPD. The aim of this study was to describe the characteristics of IPD among Croatian children and examine the possibilities of introducing different PCVs in our population.


METHODS
Streptococcus pneumoniae isolates causing IPD during three years (2001, 2005, 2006) in Croatian children younger than 14 years old were collected prospectively. Epidemiological and clinical parameters, results of serotyping, and antimicrobial susceptibility data were evaluated.


RESULTS
One hundred strains were collected during the study period. The ages of the patients ranged from 30 days to 13 years (median: 25.5 months). Seventy-nine percent of the isolates were from patients younger than five years old. The incidence of IPD was highest among children younger than two years of age (33.9/100,000). Serotypes 14, 6B, 18C, and 23F accounted for 67% of all serotypes. The overall coverage rates of PCV7, PCV10, and PCV13 were 72%, 80%, and 90%, respectively. Low-level resistance to penicillin was found in 20% of the isolates and high resistance to erythromycin in 33.8%. PCV7 covered 85% of the penicillin-resistant strains and 80% of the erythromycin-resistant strains.


CONCLUSIONS
The inclusion of a PCV in the immunization program could have a considerable effect on IPD-associated morbidity among Croatian children.
Guzvinec
Marija
M
University Hospital for Infectious Diseases, Zagreb, Croatia.
Tesović
Goran
G
Tambić-Andrasević
Arjana
A
Zidovec-Lepej
Snjezana
S
Vukić
Biserka Troselj
BT
Begovac
Josip
J
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D017523:Croatia / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D007223:Infant; D008826:Microbial Sensitivity Tests; D022242:Pneumococcal Vaccines / Q000008:administration & dosage; D013290:Streptococcal Infections / Q000453:epidemiology* / Q000382:microbiology / Q000517:prevention & control; D013296:Streptococcus pneumoniae / Q000187:drug effects / Q000302:isolation & purification*
D022242:Pneumococcal Vaccines